MetLife Investment Management’s Nutanix NTNX Stock Holding History
Bought
Maintained
Sold
Other funds holding NTNX
VPM
VCM
GIM
BCI
MetLife Investment Management's NTNX Position: Q1 2026 in Review
MetLife Investment Management increased its Nutanix (NTNX) stake by 0.38% in Q1 2026, buying an estimated $21.6K and bringing the position to 135,707 shares worth $5.16M. The position accounts for 0.03% of the portfolio, ranked #608.
MetLife Investment Management first reported a position in NTNX in Q4 2017 and has held it in 22 quarters since. The position peaked at $10.5M in Q3 2025. 534 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.
- MetLife Investment Management held 135,707 shares of Nutanix worth $5.16M as of Q1 2026.
- MetLife Investment Management bought 513 Nutanix shares in Q1 2026, an estimated $21.6K.
- Nutanix made up 0.03% of MetLife Investment Management's portfolio in Q1 2026, its #608 holding.
- MetLife Investment Management first reported a position in Nutanix in Q4 2017 and has held it in 22 quarters since.
- MetLife Investment Management's Nutanix position peaked at $10.5M in Q3 2025.
- 534 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.